Mark S. Levine, Chief Legal Officer at Immunovant, Inc. (IMVT), sold 6,484 shares at $29.65 ($192K) on 2024-05-22, disclosed to the SEC on 2024-05-24.
Open-market sale of $192k IMVT by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.65 | 3,242 | $96K | 50.0% |
| 2 | $29.65 | 3,242 | $96K | 50.0% |
| Total | $29.65 avg | 6,484 | $192K | 100% |
| Filing → |
| IMVT | SELL | 2024-10-18 | $165K | — | Filing → |
| IMVT | SELL | 2024-08-23 | $206K | — | Filing → |
| IMVT | SELL | 2024-07-26 | $223K | — | Filing → |